To see the other types of publications on this topic, follow the link: Natriuretic peptides.

Books on the topic 'Natriuretic peptides'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Natriuretic peptides.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Clerico, Aldo, and Michele Emdin, eds. Natriuretic Peptides. Milano: Springer Milan, 2006. http://dx.doi.org/10.1007/88-470-0498-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1937-, Brenner Barry M., and Laragh John H. 1924-, eds. Biologically active atrial peptides. New York, NY: Raven Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Atrial natriuretic hormones. Englewood Cliffs, NJ: Prentice Hall, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Samson, Willis K., and Ellis R. Levin, eds. Natriuretic Peptides in Health and Disease. Totowa, NJ: Humana Press, 1997. http://dx.doi.org/10.1007/978-1-4612-3960-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

1937-, Brenner Barry M., and Laragh John H. 1924-, eds. Advances in atrial peptide research. New York: Raven Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Maurice Rapin Colloquia (2nd 1990 Les Baux-de-Provence, France). Atrial natriuretic factor: Physiological and clinical aspects. Paris: Flammarion Médecine-Sciences, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Workshop on Cation Transport and Nartriurietic Factors (1985 Cambridge, Mass.). Workshop on Cation Transport and Natriuretic Factors: Cambridge, Massachusetts May 13-14, 1985. Edited by Dzau Victor J, Horan Michael J, Canessa Mitzy, and American Heart Association. [Dallas, Tex.]: American Heart Association, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

American Society of Hypertension. Meeting. First Annual Meeting of the American Society of Hypertension, May 29-30, 1986 ; First World Congress on Biologically Active Atrial Peptides, May 31-June 1, 1986: Program and abstracts, Waldorf-Astoria Hotel, New York, New York. Thorofare, N.J: The Society, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

F, Mantero, and Vecsei Pál, eds. Corticosteroids and peptide hormones in hypertension. New York: Raven Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

E, Wierman Margaret, ed. Diseases of the pituitary: Diagnosis and treatment. Totowa, N.J: Humana Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Speake, Paul Frederick. In vitro stimulation of atrial natriuretic peptide secretion from Guinea Pig atria. Manchester: University of Manchester, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Clerico, Aldo, and Michele Emdin. Natriuretic Peptides. Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Atrial natriuretic peptides. New York: Churchill Livingstone, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

1947-, Samson Willis Kendrick, and Quirion Remi 1955-, eds. Atrial natriuretic peptides. Boca Raton, Fla: CRC Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

D, Struthers Allan, ed. Atrial natriuretic factor. Oxford: Blackwell Scientific, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

D, Struthers Allan, ed. Atrial natriuretic factor. Oxford: Blackwell Scientific, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Volpe, Massimo, Speranza Rubattu, Amie Moyes, Adrian J. Hobbs, S. Jeson Sangaralingham, and John C. Burnett, eds. Natriuretic Peptides in Cardiovascular Pathophysiology. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-321-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

1937-, Brenner Barry M., and Stein Jay H. 1937-, eds. Atrial natiuretic peptides. Churchill Livingstone, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Samson, Willis K., and Ellis Levin. Natriuretic Peptides in Health and Disease. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Samson, Willis K., and Ellis Levin. Natriuretic Peptides in Health and Disease. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

1947-, Samson Willis Kendrick, and Levin Ellis R, eds. Natriuretic peptides in health and disease. Totowa, N.J: Humana Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Clerico, Aldo, and Michele Emdin. Natriuretic Peptides: The Hormones of the Heart. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Clerico, Aldo, and Michele Emdin. Natriuretic Peptides: The Hormones of the Heart. Springer London, Limited, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

J, Mulrow Patrick, and Schrier Robert W, eds. Atrial hormones and other natriureticfactors. Bethesda, Md: American Physiological Society, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

1926-, Mulrow Patrick J., and Schrier Robert W, eds. Atrial hormones and other natriuretic factors. Bethesda, Md: American Physiological Society, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Schrier, Robert W., and Patrick J. Mulrow. Atrial Hormones and Other Natriuretic Factors. Springer, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Clerico, Aldo, and Michele Emdin. Natriuretic Peptides: The Hormones of the Heart. Springer, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Progress in atrial peptide research. New York: Raven Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

1939-, Needleman Philip, and UCLA Symposium on the Biological and Molecular Aspects of Atrial Factors (1988 : Steamboat Springs, Colo.), eds. Biological and molecular aspects of atrial factors: Proceedings of a director's sponsors-UCLA symposium held at Steamboat Springs, Colorado, January 17-23, 1988. New York: Liss, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Pandey, Kailash N. Natriuretic Peptides: Physiology, Molecular Biology, and Clinical Implications. Nova Science Publishers, Incorporated, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Atrial Natriuretic Factor (Frontiers in Pharmacology & Therapeutics). Blackwell Science Inc, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Choudhary, Rajiv, Kevin Shah, and Alan Maisel. Biomarkers in acute heart failure. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199687039.003.0037_update_002.

Full text
Abstract:
Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriureticfc peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.
APA, Harvard, Vancouver, ISO, and other styles
33

Choudhary, Rajiv, Kevin Shah, and Alan Maisel. Biomarkers in acute heart failure. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199687039.003.0037_update_003.

Full text
Abstract:
Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriureticfc peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.
APA, Harvard, Vancouver, ISO, and other styles
34

Molecular Basis of Cardiovascular Diseases: Implications of Natriuretic Peptides. MDPI, 2019. http://dx.doi.org/10.3390/books978-3-03921-583-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Hurley, Karen M. The natriuretic peptides as neuromodulators in the central nervous system. 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Choudhary, Rajiv, Kevin Shah, and Alan Maisel. Biomarkers in acute heart failure. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0037.

Full text
Abstract:
Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.
APA, Harvard, Vancouver, ISO, and other styles
37

Choudhary, Rajiv, Kevin Shah, and Alan Maisel. Biomarkers in acute heart failure. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0037_update_001.

Full text
Abstract:
Acute heart failure continues to be a worldwide medical problem, associated with frequent readmissions, high mortality, and a profound economic impact on national health care systems. In the past decade, biomarkers have shifted the way in which acute heart failure is managed by the cardiologist. The search for the ideal biomarker to aid in the diagnosis, prognosis, and treatment of acute heart failure is ongoing. The natriuretic peptides have proved extremely useful in determining whether acute dyspnoea has a cardiac aetiology. In addition, recent trials have demonstrated the use of natriuretic peptides in inpatient and outpatient prognosis, as well as in titrating medications in outpatients with chronic heart failure to prevent acute heart failure hospitalizations. Other emerging acute heart failure biomarkers include mid-regional pro-adrenomedullin, mid-regional proatrial natriuretic peptide, troponin, ST2, and neutrophil gelatinase-associated lipocalin.
APA, Harvard, Vancouver, ISO, and other styles
38

1939-, Forssmann W. G., Scheuermann D. W, and Alt J, eds. Functional morphology of the endocrine heart. Dardstadt, Germany: Steinknopff-Varlag, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Forssmann, W. G., W. Scheuermann, and J. Alt. Functional Morphology of the Endocrine Heart. Steinkopff, Dietrich, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Forssmann, W. G., W. Scheuermann, and J. Alt. Functional Morphology of the Endocrine Heart. Steinkopff, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

The effect of atrial natriuretic factor on blood pressure. 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

The effect of atrial natriuretic factor on blood pressure. 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Rahimi, Kazem. Chronic heart failure. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0092.

Full text
Abstract:
The European Society of Cardiology defines heart failure as a clinical syndrome in which patients have the following features: symptoms typical of heart failure (breathlessness, fatigue, ankle swelling); signs typical of heart failure (tachycardia, tachypnoea, pulmonary crackles, pleural effusion, raised jugular venous pressure, peripheral oedema, hepatomegaly); and objective evidence of a structural or functional abnormality of the heart at rest (cardiomegaly, third heat sound, cardiac murmurs, abnormality on the echocardiogram, raised natriuretic peptide concentration). Heart failure results in activation of the sympathetic nervous system and the renin–aldosterone–angiotensin system, and release of a number of hormones such as natriuretic peptides, and cytokines, including tumour necrosis factor amongst others. While neurohormone activation is initially compensatory and helps in the short term to maintain circulatory needs, ultimately it has detrimental effects on the myocardium and compromises its function further. These mechanisms are therefore therapeutic targets to improve symptoms and lessen the risk of death.
APA, Harvard, Vancouver, ISO, and other styles
44

The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure. Glasgow: NHS Quality Improvement Scotland, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Scotland, NHS Quality Improvement, ed. The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure. Glasgow: NHS Quality Improvement Scotland, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

S, Stokes G., Marwood J. F. 1946-, and International Congress of Pharmacology (10th : 1987 : Sydney, N.S.W.), eds. Sodium transport inhibitors. Basel: Karger, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

J, Craig, and NHS Quality Improvement Scotland, eds. The Use of B-type natriuretic peptides (BNP and NT-proBNP) in the investigation of patients with suspected heart failure. Glasgow: NHS Quality Improvement Scotland, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Wierman, Margaret E. Diseases of the Pituitary: Diagnosis and Treatment. Humana Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Diseases of the Pituitary: Diagnosis and Treatment. Humana Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Wierman, Margaret E. Diseases of the Pituitary: Diagnosis and Treatment. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography